1. Home
  2. GAUZ vs ALDX Comparison

GAUZ vs ALDX Comparison

Compare GAUZ & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • ALDX
  • Stock Information
  • Founded
  • GAUZ 2009
  • ALDX 2004
  • Country
  • GAUZ Israel
  • ALDX United States
  • Employees
  • GAUZ N/A
  • ALDX N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAUZ Miscellaneous
  • ALDX Health Care
  • Exchange
  • GAUZ Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • GAUZ 180.1M
  • ALDX 160.8M
  • IPO Year
  • GAUZ 2024
  • ALDX 2014
  • Fundamental
  • Price
  • GAUZ $8.60
  • ALDX $3.05
  • Analyst Decision
  • GAUZ Strong Buy
  • ALDX Strong Buy
  • Analyst Count
  • GAUZ 4
  • ALDX 2
  • Target Price
  • GAUZ $15.50
  • ALDX $9.50
  • AVG Volume (30 Days)
  • GAUZ 23.9K
  • ALDX 792.5K
  • Earning Date
  • GAUZ 08-07-2025
  • ALDX 07-31-2025
  • Dividend Yield
  • GAUZ N/A
  • ALDX N/A
  • EPS Growth
  • GAUZ N/A
  • ALDX N/A
  • EPS
  • GAUZ N/A
  • ALDX N/A
  • Revenue
  • GAUZ $101,165,000.00
  • ALDX N/A
  • Revenue This Year
  • GAUZ $28.49
  • ALDX N/A
  • Revenue Next Year
  • GAUZ $47.77
  • ALDX N/A
  • P/E Ratio
  • GAUZ N/A
  • ALDX N/A
  • Revenue Growth
  • GAUZ 18.63
  • ALDX N/A
  • 52 Week Low
  • GAUZ $6.78
  • ALDX $1.14
  • 52 Week High
  • GAUZ $14.44
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • ALDX 61.89
  • Support Level
  • GAUZ N/A
  • ALDX $2.60
  • Resistance Level
  • GAUZ N/A
  • ALDX $3.24
  • Average True Range (ATR)
  • GAUZ 0.00
  • ALDX 0.22
  • MACD
  • GAUZ 0.00
  • ALDX 0.09
  • Stochastic Oscillator
  • GAUZ 0.00
  • ALDX 80.93

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: